Ma Sarada Hospital Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
- Paid Up Capital ₹ 3.50 M
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.06 Cr
- Revenue Growth -10.44%
- Profit Growth 136.48%
- Ebitda 8.50%
- Net Worth 0.97%
- Total Assets -11.07%
About Ma Sarada Hospital
Ma Sarada Hospital Private Limited (MSHPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 September 2012 and has a history of 12 years and four months. Its registered office is in Hooghly, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹2.06 Cr.
Sobhan Chattopadhyay and Prajapati Chatterjee serve as directors at the Company.
Company Details
-
Location
Hooghly, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U93000WB2012PTC186359
-
Company No.
186359
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Sep 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Ma Sarada Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sobhan Chattopadhyay
|
Director | 25-Sep-2012 | Current |
|
Prajapati Chatterjee
|
Director | 25-Sep-2012 | Current |
Financial Performance of Ma Sarada Hospital.
Ma Sarada Hospital Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.44% decrease. The company also saw a substantial improvement in profitability, with a 136.48% increase in profit. The company's net worth moved up by a moderate rise of 0.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ma Sarada Hospital?
In 2023, Ma Sarada Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹20.61 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Others | ₹0.42 M | Open |
| 08 Jun 2015 | Others | ₹2.02 Cr | Open |
How Many Employees Work at Ma Sarada Hospital?
Ma Sarada Hospital has a workforce of 10 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ma Sarada Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ma Sarada Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.